RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/37958978http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/37958978http://www.w3.org/2000/01/rdf-schema#comment"Neuroinflammation driven primarily by microglia directly contributes to neuronal death in many neurodegenerative diseases. Classical anti-inflammatory approaches aim to suppress pro-inflammatory mediator production, but exploitation of inflammatory resolution may also be of benefit. A key driver of peripheral inflammatory resolution, formyl peptide receptor 2 (Fpr2), is expressed by microglia, but its therapeutic potential in neurodegeneration remains unclear. Here, we studied whether targeting of Fpr2 could reverse inflammatory microglial activation induced by the potent bacterial inflammogen lipopolysaccharide (LPS). Exposure of murine primary or immortalised BV2 microglia to LPS triggered pro-inflammatory phenotypic change and activation of ROS production, effects significantly attenuated by subsequent treatment with the Fpr2 agonist C43. Mechanistic studies showed C43 to act through p38 MAPK phosphorylation and reduction of LPS-induced NFκB nuclear translocation via prevention of IκBα degradation. Here, we provide proof-of-concept data highlighting Fpr2 as a potential target for control of microglial pro-inflammatory activity, suggesting that it may be a promising therapeutic target for the treatment of neuroinflammatory disease."xsd:string
http://purl.uniprot.org/citations/37958978http://purl.org/dc/terms/identifier"doi:10.3390/ijms242115996"xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/author"Getting S.J."xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/author"McArthur S."xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/author"Biggs C."xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/author"Elliott B.T."xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/author"Wickstead E.S."xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/author"Pokorny S."xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/name"Int J Mol Sci"xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/pages"15996"xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/title"Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFkappaB Activity."xsd:string
http://purl.uniprot.org/citations/37958978http://purl.uniprot.org/core/volume"24"xsd:string
http://purl.uniprot.org/citations/37958978http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/37958978
http://purl.uniprot.org/citations/37958978http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/37958978
http://purl.uniprot.org/uniprot/#_O88536-mappedCitation-37958978http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37958978
http://purl.uniprot.org/uniprot/#_P25799-mappedCitation-37958978http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37958978
http://purl.uniprot.org/uniprot/#_Q61723-mappedCitation-37958978http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37958978
http://purl.uniprot.org/uniprot/Q61723http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/37958978
http://purl.uniprot.org/uniprot/O88536http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/37958978
http://purl.uniprot.org/uniprot/P25799http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/37958978